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Introduction
Multicentric carpotarsal osteolysis syndrome (MCTO) is a
rare autosomal dominant disorder, characterized by aggres-
sive osteolysis of the carpal and tarsal bone, and progres-
sive nephropathy leading to end-stage renal disease.
Recently, heterozygous mutations in MAFB gene within a
short region of the amino-terminal transcriptional activa-
tion domain had been reported to cause MCTO. Although
affected patients suffer from early childhood with a clinical
appearance mimicking juvenile idiopathic arthritis, most of
anti-rheumatic agents are ineffective to control their pain.
Patients and methods
A fifteen year old boy was born to healthy parents. There
was no family history of consanguinity, skeletal disorders,
and rheumatic disorders. He was well until 26 months of
age, when he showed claudication symptoms. He was
referred for painful and swollen feet, wrists and pes cavus.
He also had craniofacial abnormalities of micrognathia,
hypotelorism, chubby cheeks and flat face. He showed gra-
dual progression of osteolysis predominantly in the carpal
and tarsal bones, and progressive nephropathy with hema-
toproteinuria. Whole exome sequencing analysis detected
a de novo heterozygous mutation in MAFB gene which
was confirmed by Sanger sequencing. Because this muta-
tion had been reported as a responsible mutation of
MCTO, we diagnosed the patient as MCTO caused by the
mutation. Until this point, he was treated as a relative dis-
ease of juvenile idiopathic arthritis with non-steroidal anti-
inflammatory agents, methotrexate, which was not effec-
tive to relieve not only osteolysis but articular pain of the
patient. At the age of five, he was started to treat with
intravenous infliximab by which pain decreased and even-
tually disappeared in a mean time. Proggressive osteolysis
of the carpal and tarsal bone continued and the deformity
of fingers was evolved. Therefore, at the age of eight, his
biologics was changed to intravenous tocilizumab every
6 weeks. After 3 months treatment, the pain and tender-
ness in his wrists and fingers disappeared.
Results
Intravenous tocilizumab every 6 weeks, resulted in remark-
able improvement of his articular pain, although osteolysis
of the patient remained progressing. The patient became
free to pain and could do personal care without difficulty.
Conclusion
Tocilizumab could be an effective therapy for relief of
articular pain of MCTO.
Consent to publish
Written informated consent for publication of their clini-
cal details was obtained from the patient/parent/guardian/
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